Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1981;1(2):81-96.

Early changes in the radiosensitivity of Corynebacterium parvum-stimulated CFU-S

  • PMID: 7348462
Comparative Study

Early changes in the radiosensitivity of Corynebacterium parvum-stimulated CFU-S

Y Maruyama et al. Stem Cells (1981). 1981.

Abstract

Corynebacterium parvum injected intraperitoneally into C57BL mice induced a progression of hemopoietic CFU-S of C57BL mice from the resting state immediately after, and in the early period (approximately 8 h) after stimulation. Dose-response survival curves of the stimulated endogenous spleen CFU-S after the C. parvum injection revealed changing slopes or D0 of dose-response survival curves indicative of changing sensitivity states. Shortly after stimulation, the cells were sensitive to high specific-activity tritiated thymidine (HSATT) or hydroxyurea (HU), indicating they were in the DNA-S phase. This commenced shortly after the C. parvum injection. Beginning at about 6 h, sensitivity to HSATT disappeared and there was an increase in radiosensitivity. Sensitivity to vinblastine (VLB) also became evident at 7 h. This was consistent with beginning mitosis and mitotic cell sensitivity to VLB. A dose-response survival curve for the G2 phase CFU-S was determined using both HSATT and VLB to eliminate the DNA-S phase and mitotic cells. The radiosensitivities of the resting G1, S, and G1-S phase cells were determined by D0 to be 80, 105 and 85 rad, respectively, measured in vivo. G2 sensitivity using a combined HSATT and VLB method showed a complex, bending dose-response curve with a terminal D0 of 58 rad. CFU-S progression was blocked by the anti-histamine H2 receptor agent, metiamide.

PubMed Disclaimer

Similar articles

Publication types

LinkOut - more resources